TY  - GEN 
AU  - Laeremans, H.
AU  - Turner, C.
AU  - Andersson, T.
AU  - Cocho de Juan, José Ángel
AU  - Gerrard, A.
AU  - Heiner-Fokkema, M. R.
AU  - Herebian, D.
AU  - Janzen, N.
AU  - la Marca, G.
AU  - Rudebeck, M.
PY  - 2020
SN  - 2192-8304
UR  - http://hdl.handle.net/20.500.11940/16524
AB  - Background: Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) by preventing accumulation of toxic metabolites, including succinylacetone (SA). Accurate quantification of SA during newborn screening is essential, as is quantification of...
TI  - Inter-laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples
DO  - 10.1002/jmd2.12112
KW  - CHUS
VL  - 53
ER  -